Cutaneous mastocytosis

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 30.07.2023

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Generic term for clinically heterogeneous clinical pictures characterized by mast cell hyperplasia in the skin (and in internal organs). The spectrum ranges from solitary skin tumors to variously pronounced (variants of the so-called"urticaria pigmentosa"), in extreme cases erythrodermic skin manifestations.

The term "cutaneous mastocytosis" implies a purely cutaneous clinical picture. This is mostly found in children, less frequently in adults. Adult forms of mastocytosis are usually a "systemic disease" with a differently accentuated extracutaneous pattern of infestation, in which the cutaneous infestation can be regarded as a monitory and thus frequently leading to a diagnosis.

Tryptase: If systemic mastocytosis is suspected, tryptase is determined according to the guidelines (standard value: <20µg/l). If the value is exceeded, systemic mastocytosis is considered possible and a bone marrow biopsy and screening for other systemic involvement is sought. At low levels, extensive diagnostic testing is usually not performed without compelling clinical evidence. In a larger study, systemic mastocytosis could be confirmed in 32% of patients with cutaneous mastocytosis by bone marrow histology. In addition, N-methylhistamine or 1,4-methylimidazole acetic acid can be determined in the collected urine.

ClassificationThis section has been translated automatically.

Depending on the clinic, the following forms are distinguished among the cuntanous mastocytoses (classification of mastocytoses, modified according to Golkar)

mastocytoma(s)

Diffuse cutaneous mastocytosis

Adult cutaneous mastocytosis (maculopapular CM = MPCM)

Cutaneous mastocytosis of childhood

  • Maculopapular cutaneous mastocytosis (Urticaria pigmentosa) (classic type = MPCM)
  • Teleangiectasia macularis eruptiva perstans (extremely rare in childhood)

Special forms (old nomenclature)

  • Urticaria pigmentosa haemorrhagica
  • Exanthematic urticaria pigmentosa
  • Urticaria pigmentosa bullosa
  • Urticaria pigmentosa xanthelasmoidea

LiteratureThis section has been translated automatically.

  1. Di Raimondo C et al (2021) Cutaneous mastocytosis: A dermatological perspective. Australas J Dermatol 62:e1-e7.
  2. Fox WT (1875) On xanthelasmoidea (an undescribed eruption). Trans Clin Soc London 8: 53
  3. Frieri M et al (2013) Pediatric mastocytosis: A review of the literature. Pediatr Allergy Immunol Pulmonol 26:175-180.
  4. Golkar L, Bernard JD (1997) Mastocytosis. Lancet 349: 1379-1385
  5. Méni C et al (2015) Paediatric mastocytosis: a systematic review of 1747 cases. Br J Dermatol 172:642-651
  6. Sukesh MS et al (2014) Solitary mastocytoma treated successfully with topical tacrolimus. F1000Res 3:181

Authors

Last updated on: 30.07.2023